"Helen's demonstrated leadership of Onyx's oncology products will build on Halozyme's trajectory of value creation, pivoting from partnered to proprietary products," said
Prior to Onyx, Dr. Torley spent 14 years in management positions at
In reflecting on his 15 years at Halozyme, Dr. Frost said, "I am very proud of the multiple scientific, development, and regulatory milestones the team has achieved to date. I look forward to supporting Halozyme's next chapter of transformative healthcare in my capacity of leading the
"It is truly an honor to be joining Halozyme," said Dr. Torley. "I am excited by the unique portfolio of proprietary products in clinical testing for the treatment of cancer, diabetes and cellulite, and by the multiple royalty-based partnerships that clearly point to a talented team with a proven track record."
RJ Kirk, Halozyme's largest shareholder and member of the Board of Directors commented, "Halozyme has successfully transitioned over the last several years from being science-driven to become commercially-oriented. This is a very fortunate position to be in for any company. I laud the efforts by Greg in leading the Company to its present position with multiple product approvals under its belt. Halozyme's advanced, proprietary products are game-changing for the Company, and we must be prepared to maximize the realization of its commercial opportunities. Helen is an ideal choice to lead the company at this important moment in its trajectory."
Keywords for this news article include: Biotechnology Companies,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC
Most Popular Stories
- Koch Brothers Step up Anti-Obamacare Campaign
- FDIC Sues Big Banks Over Rate Manipulation
- Vybz Kartel Convicted of Murder
- SoCalGas Reaches Record Spend on Diversity Suppliers
- FDIC Accuses Big Banks of Fraud, Conspiracy
- Stocks Close Lower Ahead of Crimea Vote
- U.S. Consumer Sentiment Falls in Early March
- Jittery Investors Dumping Russian Stocks
- Is Malaysian Airlines Flight 370 in Andaman Sea?
- Ulta Shares Look Good on Strong Q4